Cancer Risk Associated with Alcohol and Tobacco Use
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
State of Science Alcohol and Cancer Fact Sheet
Alcohol and Cancer Basic description Research shows that alcohol consumption is linked to an increased chance of developing certain cancers. The more alcohol a person consumes, the higher their risk of developing some kinds of cancer. The way alcohol causes cancer isn’t completely understood. It could be that alcohol itself causes cancer by increasing hormone levels, or it may be carcinogenic because of the way it is metabolized, which can make cells more vulnerable to other carcinogens, like tobacco. People who drink heavily and smoke cigarettes or use other kinds of tobacco are at even higher risk for certain cancers. Cancers affected Oral, esophageal, laryngeal, and pharyngeal cancers are more common in alcohol users than in non-alcohol users. Smokers who also drink are at much higher risk. Although the combination of tobacco and alcohol use significantly increases the risk of developing these cancers, alcohol use alone also increases the risk of developing them. Alcohol is also a major cause of liver cancer. Deaths from liver cancer are higher among heavy alcohol users than among people who don’t drink. By altering the liver’s ability to metabolize some carcinogenic substances into harmless compounds or to disable certain existing carcinogens, alcohol’s effects may influence not only liver cancer but other cancers as well. Many studies have found a link between alcohol use and the risk of breast cancer. The risk increases with the amount of alcohol consumed. It’s highest among heavy alcohol users, but even a few drinks a week may increase a person’s risk. Alcohol use has been linked with a higher risk of cancers of the colon and rectum. -
Menstrual and Reproductive Factors, Hormone Use and Risk of Pancreatic Cancer: Analysis from the International Pancreatic Cancer Case-Control Consortium (Panc4)
HHS Public Access Author manuscript Author ManuscriptAuthor Manuscript Author Pancreas Manuscript Author . Author manuscript; Manuscript Author available in PMC 2017 November 01. Published in final edited form as: Pancreas. 2016 November ; 45(10): 1401–1410. doi:10.1097/MPA.0000000000000635. Menstrual and Reproductive Factors, Hormone Use and Risk of Pancreatic Cancer: Analysis From the International Pancreatic Cancer Case-Control Consortium (Panc4) Leila Lujan-Barroso, MsC, Unit of Nutrition and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology (ICO), Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain Wei Zhang, PhD, Department of Epidemiology, Shanghai Cancer Institute and Jiao Tong University, Shanghai, China Sara H. Olson, PhD, Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY Yu-Tang Gao, PhD, Department of Epidemiology, Shanghai Cancer Institute and Jiao Tong University, Shanghai, China Herbert Yu, PhD, Epidemiology Program, University of Hawaii Cancer Center, Honolulu, HI, USA Peter A. Baghurst, PhD, Public health, Women’s and Children’s Hospital, Adelaide, SA, Australia Paige M. Bracci, PhD, University of California, San Francisco, San Francisco, CA, USA H. Bas Bueno-de-Mesquita, MD, PhD, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands Department of Gastroenterology and Hepatology, University Medical Center Utrecht, Utrecht, The Netherlands Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK Department of Social and Preventive Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia Lenka Foretová, PhD, Corresponding author: Eric J Duell, MS, PhD, Senior Investigator/Epidemiologist, Unit of Nutrition and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology (ICO-IDIBELL), Avda Gran Via 199-203, 08908 L'Hospitalet de Llobregat, Barcelona, Spain, tel: +34 93 260 7401 (ext 3354), fax: +34 93 260 7787, [email protected]. -
Meal Frequency and Risk of Colorectal Cancer1
[CANCER RESEARCH 52. 3589-3592. July 1, 1992] Meal Frequency and Risk of Colorectal Cancer1 Silvia Franceschi,2 Carlo La Vecchia, Ettore Bidoli, Eva Negri, and Renato Talamini Epidemiology Unit, Aviario Cancer Center, Via Pedemontana Occidentale, 33081 Avlano (PN), [S. F., E. B., R. T.]; Mario Negri Institute for Pharmacological Research, Via Eritrea 62, 20157 Milan fC. L. K, E. N.J, Italy; and Institute of Social and Preventive Medicine, University of Lausanne, Bugnon 17, 1005 Lausanne, Switzerland 1C. L. V.J ABSTRACT PATIENTS AND METHODS The relation between meal frequency and the risk of colorectal cancer The present data were derived from an ongoing case-control study was investigated in a case-control study conducted in North Italy on 889 of several neoplasms of the digestive tract based on a network of cases of colon cancer, 581 cases of rectal cancer, and 2475 controls teaching and general hospitals from Greater Milan area and Pordenone province, North Italy (8-12). Recruitment of cases of colorectal cancer admitted to hospital for acute, nonneoplastic, or digestive disorders. As compared to individuals who reported 2 or fewer meals per day, the started in January 1985. All the interviews were conducted in hospital mull¡variatecolon cancer odds ratios were 1.7 [95% confidence interval before December 1990 and approximately 2% of cases and 3% of (95% CI), 1.5-2.11 for 3, and 1.9 (95% CI, 1.1-3.3) for 4 meals or more. control subjects refused to be interviewed. Corresponding rectal cancer odds ratios were 1.4 (95% CI, 1.1-1.7) for The cases studied were subjects with histologically confirmed large 3, and 1.9 (95% CI, 1.1-3.5) for 4 meals or more. -
Monday, 4Th November 2019 Cohort Updates Progress in ACC Research
PROGRAM 2019 ANNUAL MEETING OF ACC – ILCEC: ONCOLOGY RESEACH & APPLICATION OF BIOBANK Vinmec International Clinic, Hanoi 4th – 6th November 2019 Time Topic Presenter Monday, 4th November 2019 8:00 – 10:00 ACC Executive Committee (closed meeting) ACC Executive Committee members 9:30-10:00 Registration Opening Prof. Paolo Boffetta 10:00 – 10:30 Welcome; Opening remarks Icahn School of Medicine at Mount Sinai, USA Manami Inoue, Eiko Saito, Sarah K. Abe, 10:30 – 11:00 Update of the ACC Coordinating Center Rashedul Islam National Cancer Center, Japan Cohort Updates Dr. Arash Etemadi 11:00 – 11:15 Persian Cohort National Cancer Institute, NIH Dr. Yi-Ling Lin 11:15 – 11:30 Taiwan Biobank update Institute of Biomedical Sciences, Academia Sinica, Taiwan Dr. Xifeng Wu 11:30 – 11:45 Taiwan cohort Prof. Rui Lin 11:45 – 12:00 Guangxi Cohort Guangxi Medical University, China 12:00 – 13:30 Lunch (Visit to Vinmec Hospital) Prof. Keun-Young Yoo 13:30-14:00 Plenary lecture Seoul National University College of Medicine, Korea Progress in ACC research (15 min each) Acute effect of ambient air pollution on health in PhD. Nguyen Thi Trang Nhung 14:00 – 14:15 Northern Vietnam Hanoi University of Public Health, Vietnam PM concentration mapping from satellite images PhD. Nguyen Thi Nhat Thanh 14:15 – 14:30 for health impact assessment in Vietnam Vietnam National University Dr. George Downward Long-term ambient air pollution and mortality in 14:30 – 14:45 Institute for Risk Assessment Sciences, Utrecht the ACC, project update University, Netherlands Household Air Pollution Consortium (HAPCO) A/Prof. Dean Hosgood 14:45 – 15:00 updates Albert Einstein College of Medicine, USA 15:00 – 15:30 Coffee break (Poster session) Lifetime Overweight and Obesity: Impact on Dr. -
Medical History and Primary Liver Cancer1
[CANCER RESEARCH 50, 6274-6277. October I. 1990] Medical History and Primary Liver Cancer1 Carlo La Vecchia, Eva Negri, Barbara D'Avanzo, Peter Boyle, and Silvia Franceschi Istituto di Ricerche Farmaco/logiche "Mario Negri," 20157 Milan, Italy [C. L. V., E. N., B. D.]; Institute of Social and Preventive Medicine, University of Lausanne, Lausanne, Switzerland ¡C.L. V.¡;Unitof Analytical Epidemiology, The International Agency for Research on Cancer, Lyon, France ¡P.B.f;and Servizio di Epidemiologia, Centro di Riferimento Oncologico, 33081 Ariano (PN), Italy [S. F.] ABSTRACT The general structure of this investigation has already been described (12). Briefly, trained interviewers identified and questioned cases and The relationship between selected aspects of medical history and the controls in the major teaching and general hospitals of the Greater risk of primary liver cancer was analyzed in a hospital-based case-control Milan area. The structured questionnaire included information on study conducted in Northern Italy on 242 patients with histologically or sociodemographic characteristics, smoking habits, alcohol drinking, serologically confirmed hepatocellular carcinoma and 1169 controls in intake of coffee and 14 selected indicator foods, and a problem-oriented hospital for acute, nonneoplastic, or digestive diseases. Significant asso medical history including 12 selected diseases or interventions. By ciations were observed for clinical history of hepatitis (odds ratio (OR), definition, the diseases or interventions considered had to anticipate by 3.7; 95% confidence interval (CI), 2.3-5.9], cirrhosis (OR, 16.8; 95% CI, at least 1 year the onset of the symptoms of the disease which led to 9.8-28.8), and three or more episodes of transfusion in the past (OR, admission. -
The Impact of Alcohol on Health
The impact of alcohol on health Peter Anderson Introduction Apart from being a drug of dependence, alcohol has been known for many years as a cause of some 60 different types of disease and condition, including injuries, mental and behavioural disorders, gastrointestinal conditions, cancers, cardiovascular diseases, immunological disorders, lung diseases, skeletal and muscular diseases, reproductive disorders and pre-natal harm, including an increased risk of prematurity and low birth weight (Anderson & Baumberg, 2006). In recent years, overwhelming evidence has confirmed that both the volume of lifetime alcohol use and the combination of frequency of drinking and amount drunk per incident increase the risk of alcohol-related harm, largely in a dose-dependent manner (WHO Regional Office for Europe, 2009; Rehm et al., 2010) with the higher the alcohol consumption, the greater the risk. For some conditions, such as cardiomyopathy, acute respiratory distress syndrome and muscle damage, harm appears only to result from a sustained level of high alcohol consumption, but even at high levels, alcohol increases the risk and severity of these conditions in a dose- dependent manner. The frequency and volume of episodic heavy drinking are of particular importance for increasing the risk of injuries and certain cardiovascular diseases (coronary heart disease and stroke). Although there is a protective effect of light to moderate drinking on ischaemic diseases, overwhelmingly alcohol is toxic to the cardiovascular system. Alcohol is an intoxicant affecting a wide range of structures and processes in the central nervous system which, interacting with personality characteristics, associated behaviour and sociocultural expectations, are causal factors for intentional and unintentional injuries and harm to both the drinker and others. -
References 263
7. REFERENeES Abel, E.L. (1978) Effect of ethanol on pregnant rats and their offspring. Psychopharmacology,57, 5-11 Abel, E.L. (1979) Sex ratio in fetal alcohol syndrome. Lancet, ii, 105 Abel, E.L. (1980) Fetal alcohol syndrome: behavioral teratology. Psycho 1. Bull., 87, 29-50 Abel, E.L. (1981) Fetal Alcohol Syndrome, VoL. 1, Boca Raton, FL, CRe Press Abel, E.L. (1985a) Prenatal effects of alcohol on growth: a brief overview. Fed. Proc., 44, 2318-2322 Abel, E.L. (1985b) Alcohol enhancement of marijuana-induced fetotoxicity. Teratology, 31, 35-40 Abel, E.L. & Dintcheff, RA. (1978) Effects of prenatal alcohol exposure on growth and development in rats. J. Pharmacol. exp. Ther., 207,916-921 Abel, E.L. & Dintcheff, RA. (1986) Saccharin preference in animaIs prenatally exposed to alcohol: no evidence of altered sexual dimorphism. Neurobehav. Toxicol. Teratol., 8, 521-523 Abel, E.L. & Greizerstein, H.R (1979) Ethanol-induced prenatal growth deficiency: changes in fetal body composition. J. Pharmacol. exp. Ther., 211,668-671 Abernethy, D.J., Frazelle, J. H. & Boreiko, C.J. (1982) Effects of ethanol, acetaldehyde and acetic acid in the C3Hj lOT1j2 CL8 cell transformation system (Abstract No. Bf-l). Environ. Mutagenesis, 4,331 Adam, L. & Postel, W. (1987) Gas chromatographie analysis of ethyl carbamate (urethane) in spirits (GeL). Branntweinwirtschaft, March, 66-68 Addiction Research Foundation (1985) Statistics On Alcohol and Drug Use in Canada and Other Countries, VoL. 1, Statistics on Alcohol Use, Toronto, pp. 214-218 Adelhardt, M., Jensen, O.M. & Hansen, H.S. (1985) Cancer of the larynx, pharynx, and oesophagus in relation to alcohol and tobacco consumption among Danish brewery workers. -
Alcohol Metabolism and Cancer Risk
Alcohol Metabolism and Cancer Risk Helmut K. Seitz, M.D., and Peter Becker, M.D. Chronic alcohol consumption increases the risk for cancer of the organs and tissues of the respiratory tract and the upper digestive tract (i.e., upper aerodigestive tract), liver, colon, rectum, and breast. Various factors may contribute to the development (i.e., pathogenesis) of alcohol-associated cancer, including the actions of acetaldehyde, the first and most toxic metabolite of alcohol metabolism. The main enzymes involved in alcohol and acetaldehyde metabolism are alcohol dehydrogenase (ADH) and aldehyde dehydrogenase (ALDH), which are encoded by multiple genes. Because some of these genes exist in several variants (i.e., are polymorphic), and the enzymes encoded by certain variants may result in elevated acetaldehyde levels, the presence of these variants may predispose to certain cancers. Several mechanisms may contribute to alcohol-related cancer development. Acetaldehyde itself is a cancer-causing substance in experimental animals and reacts with DNA to form cancer-promoting compounds. In addition, highly reactive, oxygen-containing molecules that are generated during certain pathways of alcohol metabolism can damage the DNA, thus also inducing tumor development. Together with other factors related to chronic alcohol consumption, these metabolism-related factors may increase tumor risk in chronic heavy drinkers. KEY WORDS: Alcohol and other drug (AOD) consumption; heavy drinking; chronic AOD use; ethanol metabolism; carcinogenesis; cancer; upper -
Sommario Biografico Prof. Carlo La Vecchia Il Prof. Carlo La Vecchia È
Sommario Biografico Prof. Carlo La Vecchia Il Prof. Carlo La Vecchia è Professore di Epidemiologia all’Università di Milano. È inoltre Adjunct Professor of Medicine, School of Medicine, Vanderbilt University, Nashville, TN (2002-2016). È temporary advisor all’Organizzazione Mondiale della Sanità a Ginevra, ed è iscritto all’Ordine dei Medici e dei Giornalisti di Milano. I principali argomenti di interesse includono l’epidemiologia dei tumori e i rischi associati a dieta tabacco contraccettivi orali ed esposizioni occupazionali od ambientali ad agenti tossici, analisi degli andamenti temporali e della distribuzione geografica nella mortalità per tumori, malattie cardiovascolari, patologie perinatali e altre malattie importanti. È autore o coautore di oltre 2200 pubblicazioni su questi argomenti (oltre 1840 incluse in Pubmed), che hanno ricevuto oltre 75.000 citazioni (H index 123) Il Prof. La Vecchia è stato Professore Associato Aggiunto di Epidemiologia alla Harvard School of Public Health (1996-2001) , Honorary and Senior Lecturer in Medicina Stomatologica alla Eastman Dental Institute, University College London (1996-2003) . È stato Professore Straordinario di Epidemiologia, Istituto di Medicina Sociale e Preventiva, Università di Losanna, Svizzera (dal 2002-14) e Consulente Senior alla International Agency for Research on Cancer , IARC/OMS (2007-9), Capo Dipartimento di Epidemiologia all’Istituto Mario Negri, Milano (2007-14). È editor di Epidemiology,Biostatistics and Pubhlic Health. E’Associate Editor di dell’European Journal of Cancer Prevention. E’ stato Editor dell’ European Journal of Public Health e del Journal of Epidemiology and Biostatistics e Associate Editor di Annals of Oncology . Nel 2002 è stato nominato “ISI Thompson Higly quoted scientist (Medicine) e nel 2006 Commendatore della Repubblica Italiana per meriti scientifici. -
Antibody Responses to Helicobacter Pylori and Risk of Developing Colorectal Cancer in a European Cohort
Author Manuscript Published OnlineFirst on April 24, 2020; DOI: 10.1158/1055-9965.EPI-19-1545 Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. 1 Antibody responses to Helicobacter pylori and risk of developing colorectal 2 cancer in a European cohort 3 Running title (50/60 characters): Helicobacter pylori serology and colorectal cancer 4 Julia Butt†; 1) Infections and Cancer Epidemiology, German Cancer Research Center (DKFZ), 5 Heidelberg, Germany; E-mail: [email protected] 6 Mazda Jenab†; 1) International Agency for Research on Cancer (IARC-WHO), Lyon, France; E- 7 mail: [email protected] 8 Michael Pawlita; 1) Infections and Cancer Epidemiology, German Cancer Research Center 9 (DKFZ), Heidelberg, Germany; E-mail: [email protected] 10 Anne Tjønneland; 1) Diet, Genes and Environment, Danish Cancer Society Research Center, 11 Copenhagen, Denmark; E-mail: [email protected] 12 Cecilie Kyrø; 1) Diet, Genes and Environment, Danish Cancer Society Research Center, 13 Copenhagen, Denmark; E-mail: [email protected] 14 Marie-Christine Boutron-Ruault; 1) CESP, Fac. de médecine - Univ. Paris-Sud, Fac. de médecine 15 - UVSQ, INSERM, Université Paris-Saclay, 94805, Villejuif, France ; 2) Gustave Roussy, F-94805, 16 Villejuif, France; E-mail: [email protected] 17 Franck Carbonnel; 1) CESP, Fac. de médecine - Univ. Paris-Sud, Fac. de médecine - UVSQ, 18 INSERM, Université Paris-Saclay, 94805, Villejuif, France; 2) Gustave Roussy, F-94805, Villejuif, 19 France; 3) Department of Gastroenterology, Bicêtre University Hospital, Assistance Publique 20 des Hôpitaux de Paris, Le Kremlin-Bicêtre, France; E-mail: [email protected] 21 Catherine Dong; 1) CESP, Fac. -
Alcohol Use and Cancer
cancer.org | 1.800.227.2345 Alcohol Use and Cancer Alcohol use is one of the most important preventable risk factors for cancer, along with tobacco use and excess body weight. Alcohol use accounts for about 6% of all cancers and 4% of all cancer deaths in the United States. Yet many people don’t know about the link between alcohol use and cancer. Cancers linked to alcohol use Alcohol use has been linked with cancers of the: 1 ● Mouth 2 ● Throat (pharynx) 3 ● Voice box (larynx) 4 ● Esophagus 5 ● Liver 6 ● Colon and rectum 7 ● Breast Alcohol probably also increases the risk of cancer of the stomach8, and might affect the risk of some other cancers as well. For each of these cancers, the more alcohol you drink, the higher your cancer risk. But for some types of cancer, most notably breast cancer, consuming even small amounts of alcohol can increase risk. Cancers of the mouth, throat, voice box, and esophagus: Alcohol use clearly raises the risk of these cancers. Drinking and smoking together raises the risk of these cancers many times more than drinking or smoking alone. This might be because alcohol can help harmful chemicals in tobacco get inside the cells that line the mouth, 1 ____________________________________________________________________________________American Cancer Society cancer.org | 1.800.227.2345 throat, and esophagus. Alcohol may also limit how these cells can repair damage to their DNA caused by the chemicals in tobacco. Liver cancer: Long-term alcohol use has been linked to an increased risk of liver cancer. Regular, heavy alcohol use can damage the liver, leading to inflammation and scarring, which might be why it raises the risk of liver cancer. -
Epidemiology of Alcohol and Cancer1
[CANCER RESEARCH 39, 2840-2843, July1979] 0008-5472/79/0039-0000 $02.00 Epidemiology of Alcohol and Cancer1 A. J. Tuyns International Agency for Research on Cancer, Unit of Epidemiology and Biostatistics, 150 Cours Albert Thomas, 69372 Lyon Cedex 2, France Abstract as Ledermann thought is presently a matter of controversy (2, 3) and will not be discussed here. There is still insufficient knowledge of the distribution of What is undeniable, however, is the need for more surveys drinking habits in human populations, and more descriptive providing a good description of drinking habits in human pop surveysareneeded. ulations. We need to know how people consume alcohol in Both prospective and retrospective epidemiological studies terms of average daily consumption by sex, age, social class, indicate that alcohol consumption is a cancer hazard. Prospec type of drink, rhythm of drinking, and possibly by more param tive studies on excessive drinkers have shown an increased eters. Such a detailed description can only be obtained by risk for cancer of the mouth, pharynx, larynx, esophagus, liver, direct measurement within well-designed surveys. There are and lung. Retrospective studies have confirmed this excess surprisingly few surveys of this kind, and very little is known risk. For cancers of the buccal cavity, pharynx, larynx, and about the way people consume their alcohol throughout the esophagus, the effect of drinking has been shown to be asso world. This is probably the reason why little is known of the ciated with the effect of smoking. In the case of esophageal risks of developing various diseases in relation to alcohol cancer, these two effects are independent, and the observa consumption.